Sunday, March 1, 2020

Will India use coronavirus as an opportunity to end dependence on Chinese drug raw materials?

Will India use coronavirus as an opportunity to end dependence on Chinese drug raw materials? Indian pharma companies import raw materials like key starting materials, intermediates and bulk drugs worth $4.5 billion

from Moneycontrol Business News https://ift.tt/3ajBvqe

No comments:

Post a Comment

Short-term volatility may persist, but FII flows and economic activity to keep sentiment positive: Vikas Khemani

Vikas Khemani of Carnelian Asset Management remains optimistic about Indian markets, citing a strong domestic growth story and the resolutio...